615 related articles for article (PubMed ID: 25186125)
1. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
[TBL] [Abstract][Full Text] [Related]
2. A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.
Voisset C; Daskalogianni C; Contesse MA; Mazars A; Arbach H; Le Cann M; Soubigou F; Apcher S; Fåhraeus R; Blondel M
Dis Model Mech; 2014 Apr; 7(4):435-44. PubMed ID: 24558096
[TBL] [Abstract][Full Text] [Related]
3. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
5. Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.
Westhoff Smith D; Sugden B
Viruses; 2013 Jan; 5(1):226-40. PubMed ID: 23325328
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
Ressing ME; Horst D; Griffin BD; Tellam J; Zuo J; Khanna R; Rowe M; Wiertz EJ
Semin Cancer Biol; 2008 Dec; 18(6):397-408. PubMed ID: 18977445
[TBL] [Abstract][Full Text] [Related]
7. Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.
Apcher S; Daskalogianni C; Manoury B; Fåhraeus R
PLoS Pathog; 2010 Oct; 6(10):e1001151. PubMed ID: 20976201
[TBL] [Abstract][Full Text] [Related]
8. Type I arginine methyltransferases are intervention points to unveil the oncogenic Epstein-Barr virus to the immune system.
Angrand G; Quillévéré A; Loaëc N; Dinh VT; Le Sénéchal R; Chennoufi R; Duchambon P; Keruzoré M; Martins RP; Teulade-Fichou MP; Fåhraeus R; Blondel M
Nucleic Acids Res; 2022 Nov; 50(20):11799-11819. PubMed ID: 36350639
[TBL] [Abstract][Full Text] [Related]
9. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.
Jiang L; Xie C; Lung HL; Lo KW; Law GL; Mak NK; Wong KL
Theranostics; 2018; 8(19):5307-5319. PubMed ID: 30555548
[TBL] [Abstract][Full Text] [Related]
10. EBNA1.
Frappier L
Curr Top Microbiol Immunol; 2015; 391():3-34. PubMed ID: 26428370
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
[TBL] [Abstract][Full Text] [Related]
12. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
[TBL] [Abstract][Full Text] [Related]
13. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
[TBL] [Abstract][Full Text] [Related]
14. Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNA.
Lista MJ; Martins RP; Billant O; Contesse MA; Findakly S; Pochard P; Daskalogianni C; Beauvineau C; Guetta C; Jamin C; Teulade-Fichou MP; Fåhraeus R; Voisset C; Blondel M
Nat Commun; 2017 Jul; 8():16043. PubMed ID: 28685753
[TBL] [Abstract][Full Text] [Related]
15. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
16. Novel cationic bis(acylhydrazones) as modulators of Epstein-Barr virus immune evasion acting through disruption of interaction between nucleolin and G-quadruplexes of EBNA1 mRNA.
Reznichenko O; Quillévéré A; Martins RP; Loaëc N; Kang H; Lista MJ; Beauvineau C; González-García J; Guillot R; Voisset C; Daskalogianni C; Fåhraeus R; Teulade-Fichou MP; Blondel M; Granzhan A
Eur J Med Chem; 2019 Sep; 178():13-29. PubMed ID: 31173968
[TBL] [Abstract][Full Text] [Related]
17. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
Liu CD; Lee HL; Peng CW
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
[TBL] [Abstract][Full Text] [Related]
18. Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J; Jin H; Cheung KF; Tong JH; Zhang S; Go MY; Tian L; Kang W; Leung PP; Zeng Z; Li X; To KF; Sung JJ; Yu J
Cancer; 2012 Feb; 118(4):924-36. PubMed ID: 21717425
[TBL] [Abstract][Full Text] [Related]
19. A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8.
Do NV; Ingemar E; Phi PT; Jenny A; Chinh TT; Zeng Y; Hu L
Virus Res; 2008 Mar; 132(1-2):15-24. PubMed ID: 18096263
[TBL] [Abstract][Full Text] [Related]
20. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
Deakyne JS; Malecka KA; Messick TE; Lieberman PM
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]